Free Trial
→ I was right about SpaceX (From Brownstone Research) (Ad)tc pixel Free TVRD Stock Alerts

Tvardi Therapeutics (TVRD) Institutional Ownership

Tvardi Therapeutics logo
$4.00 +0.04 (+1.01%)
Closing price 04:00 PM Eastern
Extended Trading
$4.01 +0.01 (+0.37%)
As of 04:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Tvardi Therapeutics (NASDAQ:TVRD)

Current
Institutional Ownership
Percentage
44.66%
Number of
Institutional Buyers
(last 12 months)
28
Total
Institutional Inflows
(last 12 months)
$42.31M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$54.36K
Get TVRD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Tvardi Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

TVRD Institutional Buying and Selling by Quarter

Tvardi Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026Renaissance Technologies LLC92,100$293K0.0%-11.9%0.982%
2/18/2026XTX Topco Ltd12,838$55K0.0%N/A0.137%
2/18/2026Quadrature Capital Ltd20,964$90K0.0%N/A0.223%
2/17/2026 Russell Investments Group Ltd.15,966$69K0.0%+1,351.5%0.170%
2/16/2026Squarepoint Ops LLC51,783$223K0.0%+534.3%0.552%
2/16/2026 Arax Advisory Partners8,400$36K0.0%+277.2%0.090%
2/13/2026Charles Schwab Investment Management Inc.11,802$51K0.0%-22.7%0.126%
2/13/2026State Street Corp115,501$497K0.0%+83.7%1.231%
2/12/2026 Jane Street Group LLC47,444$204K0.0%N/A0.506%
2/12/2026HRT Financial LP11,050$47K0.0%N/A0.118%
2/12/2026Renaissance Technologies LLC104,500$449K0.0%+246.3%1.114%
2/12/2026 American Financial Group Inc.223,659$962K0.3%N/A2.384%
2/10/2026Goldman Sachs Group Inc.33,131$142K0.0%+37.9%0.353%
2/9/2026Geode Capital Management LLC157,133$676K0.0%+6.2%1.675%
2/5/2026 Duncan Williams Asset Management LLC80,771$347K0.1%+266.6%0.861%
11/17/2025Vestal Point Capital LP167,000$6.51M0.3%N/A1.781%
11/17/2025Parkman Healthcare Partners LLC65,000$2.53M0.3%N/A0.693%
11/14/2025Schonfeld Strategic Advisors LLC19,132$746K0.0%N/A0.204%
11/14/2025Squarepoint Ops LLC8,164$318K0.0%N/A0.087%
11/13/2025 Invesco Ltd.82,614$3.22M0.0%N/A0.881%
11/13/2025 UBS Group AG48,479$1.89M0.0%+65.2%0.517%
11/10/2025 Monaco Asset Management SAM13,590$530K0.0%N/A0.145%
11/7/2025Vanguard Group Inc.419,167$16.34M0.0%+5.2%4.470%
8/16/2025 Headlands Technologies LLC3,431$80K0.0%N/A0.037%
8/15/2025Bank of America Corp DE17,085$399K0.0%N/A0.183%
8/15/2025683 Capital Management LLC176,030$4.11M0.3%N/A1.881%
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.1,863$43K0.0%N/A0.020%
8/14/2025Slate Path Capital LP704,118$16.43M0.3%N/A7.523%
8/13/2025Marshall Wace LLP24,980$583K0.0%N/A0.267%
8/13/2025 New York State Common Retirement Fund4,000$92K0.0%N/A0.043%
8/12/2025 JPMorgan Chase & Co.1,668$39K0.0%N/A0.018%
8/8/2025Geode Capital Management LLC112,138$2.62M0.0%N/A1.198%


TVRD Institutional Ownership - Frequently Asked Questions

During the previous two years, 29 institutional investors and hedge funds held shares of Tvardi Therapeutics. The most heavily invested institutionals were Slate Path Capital LP ($16.43M), Vanguard Group Inc. ($16.34M), Vestal Point Capital LP ($6.51M), 683 Capital Management LLC ($4.11M), Invesco Ltd. ($3.22M), Parkman Healthcare Partners LLC ($2.53M), and UBS Group AG ($1.89M).Learn more on Tvardi Therapeutics' institutional investors.

44.66% of Tvardi Therapeutics' stock is owned by institutional investors. Learn more on TVRD's institutional investor holdings.

Of the 28 institutional investors that purchased Tvardi Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Slate Path Capital LP ($704.12K), American Financial Group Inc. ($223.66K), 683 Capital Management LLC ($176.03K), Vestal Point Capital LP ($167K), Geode Capital Management LLC ($121.35K), Invesco Ltd. ($82.61K), and Renaissance Technologies LLC ($74.33K).

Institutional investors have bought a total of 2,025,328 shares in the last 24 months. This purchase volume represents approximately $42.31M in transactions.

The following institutional investors have sold Tvardi Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($12.40K), and Charles Schwab Investment Management Inc. ($3.47K).

Institutional investors have sold a total of 15,872 shares in the last 24 months. This volume of shares sold represents approximately $54.36K in transactions.


Related Companies

This page (NASDAQ:TVRD) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel